Cantley Lewis Clayton Jr. 4
4 · AGIOS PHARMACEUTICALS INC · Filed Nov 15, 2017
Insider Transaction Report
Form 4
Cantley Lewis Clayton Jr.
Director10% Owner
Transactions
- Sale
Common stock
2017-11-13$62.07/sh−1,000$62,070→ 82,394 total - Sale
Common stock
2017-11-13$62.07/sh−1,000$62,070→ 82,434 total(indirect: See footnote) - Sale
Common stock
2017-11-14$59.36/sh−691$41,018→ 81,703 total - Sale
Common stock
2017-11-14$59.36/sh−691$41,018→ 81,743 total(indirect: See footnote) - Sale
Common stock
2017-11-14$60.46/sh−309$18,682→ 81,394 total - Sale
Common stock
2017-11-14$60.46/sh−309$18,682→ 81,434 total(indirect: See footnote)
Holdings
- 20,803(indirect: See footnote)
Common stock
- 20,803(indirect: See footnote)
Common stock
Footnotes (7)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $61.87 to $62.45. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F3]Shares held by Vicki Lee Sato, who is the reporting person's spouse.
- [F4]The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $59.05 to $59.71. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F5]The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $60.19 to $60.78. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F6]Shares held by grantor retained annuity trusts for the benefit of the reporting person and his two children, of which the reporting person is trustee and sole annuitant.
- [F7]Shares held by grantor retained annuity trusts for the benefit of the reporting person's spouse and their two children, of which the reporting person's spouse is trustee and sole annuitant.